表紙
市場調查報告書
商品編碼
1025459

DNA 疫苗的全球市場(2021-2027)

DNA Vaccine Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,全球 DNA 疫苗市場預計將以約 7.6% 的顯著複合年增長率增長。這一市場增長的一個主要驅動因素是,與傳統疫苗相比,DNA 疫苗降低了感染風險。由於人們對抗生素耐藥病原體和傳染病的脆弱性日益增加,預計對積極和低成本疫苗接種的日益增長的需求將推動市場的發展。此外,DNA疫苗被認為是實用的,因為它們易於構建並在感染宿主細胞之前引起抗體反應。 DNA疫苗也為開發多抗原疫苗開闢了新的戰略,這是推動市場增長的另一個因素。例如,巴斯德研究所專注於為 SARS-CoV-2 開發 DNA 疫苗。 DNA 疫苗包含最新的方法,因為使用這種技術的疫苗尚未商業化。這種疫苗在使用動物模型的測試中取得了令人鼓舞的結果。這種疫苗的臨床試驗尚未開始。

自 2019 年 12 月以來,COVID-19 大流行對全球 DNA 疫苗市場產生了積極影響。隨著世界正在努力尋找治癒這種疾病的方法,市場隨著疫苗的開發而增長。一個主要的市場參與者正專注於 COVID-19 DNA 疫苗的開發。例如,2020 年 4 月,美國生物技術公司 INOVIO Pharmaceuticals 正在測試候選疫苗以保護 Covid-19。此外,該公司最近宣佈已完成第一階段的註冊,並將於 6 月公佈試驗的初步結果。

全球 DNA 疫苗市場按類型、技術和應用進行分類。按類型,全球DNA疫苗市場分為動物DNA疫苗和人DNA疫苗。根據技術,全球DNA疫苗市場分為質粒DNA疫苗技術和質粒DNA遞送技術。根據應用,全球DNA疫苗市場分為腫瘤、傳染病等。

全球 DNA 疫苗市場按地區進行分析,這對市場增長做出了重大貢獻。按地區劃分,分為北美、歐洲、亞太等地區。在給定的預測期內,北美擁有最大的市場份額。該地區的市場正在擴大,因為它是一個發達國家,當地政府正在主動為每個人接種疫苗,該地區有主要的市場參與者,這取決於您在做什麼。 DNA疫苗的廣泛使用也有望推動北美市場的增長。

本報告調查了全球 DNA 疫苗市場,概述了市場,分析了市場增長和障礙、市場機會、市場規模趨勢以及按類型、技術、應用和地區以及競爭條件的預測。, 提供系統信息,例如主要公司的簡介。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

  • 調查範圍
  • 分析師洞察和當前市場趨勢

第 3 章競爭形勢

  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT 分析
  • 重要的戰略分析
  • COVID-19 對主要參與者的影響

第 4 章市場決定因素

  • 增長因素
  • 抑制因素
  • 市場機會

第 5 章市場細分

  • 按類型
    • 動物 DNA 疫苗
    • 人類 DNA 疫苗
  • 按技術
    • 質粒DNA疫苗技術
    • 質粒DNA遞送技術
  • 按應用程序
    • 腫瘤學
    • 傳染病
    • 其他

第 6 章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他領域

第 7 章公司簡介

  • Arbutus Biopharma
  • Astellas Pharma Inc.
  • Bayhill Therapeutics
  • Bharat Biotech International Ltd.
  • Dendreon Pharmaceuticals LLC.
  • GC Pharma Corp.
  • General Electric Co.
  • GlaxoSmithKline plc.
  • Hoffmann-La Roche Ltd
  • Indian Immunologicals Ltd.
  • INOVIO Pharmaceuticals.
  • Merck & Co., Inc.,
  • Pfizer Inc.
  • QED Bioscience Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Xenetic Biosciences, Inc.
  • Zoetis Inc.
目錄
Product Code: OMR2023891

Full-title:Global DNA Vaccine Market Size, Share & Trends Analysis Report By Type (Animal DNA Vaccine and Human DNA Vaccine), By Technology (Plasmid DNA Vaccines Technology and Plasmid DNA Delivery Technology), By Application (Oncology, Infectious Diseases, and Others) Forecast, 2021-2027.

The global DNA vaccine market is anticipated to grow at a considerable CAGR of around 7.6% during the forecast period. The key factors that impel the growth of the market include the DNA vaccine reduced risk of infection as compared to conventional vaccines. The increasing need for active and low-cost vaccination due to the rising number of antibiotics resilient pathogens and the growing vulnerability of people to contagious diseases are projected to drive the market. Moreover, DNA vaccines are easy to construct, and this approach is considered to be actual as it produces an antibody response before infecting the host cells, also DNA Vaccines have opened up a new strategy to develop multi-antigen vaccines, which are some factors that boost the growth of the market. For instance, The Institut Pasteur company is focusing on the development of a DNA vaccine for SARS-CoV-2, the DNA vaccine certainly includes the most novel methodology, since no vaccine using this technology has yet been commercialized. The vaccine has promising results in tests on animal models. The Clinical trials of this vaccine have not yet begun.

The COVID-19 pandemic has a positive impact on the global DNA vaccines market since December 2019. The market is increasing due to the development of vaccines as the globe deals to find a cure for the disease. The major market players are focusing on developing COVID-19 DNA vaccines. For instance, In April 2020, the US-based biotech company INOVIO Pharmaceuticals. Is testing a vaccine candidate to protect against Covid-19. Additionally, the company recently announced it has completed phase I enrolment and will release initial results from the trial in June.  

The global DNA vaccine market segmented based on type, technology, application. Based on type, the global DNA vaccine market is segmented into animal DNA vaccines and human DNA vaccines. Based on technology, the global DNA vaccine market is segmented into plasmid DNA vaccine technology, plasmid DNA delivery technology. Based on the application, the global DNA vaccine market is segmented into oncology, infectious diseases, and others. 

The global DNA vaccine market is analyzed based on the geographical regions that are contributing considerably towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America holds the largest market share in the given forecast period. The market is increasing in this region due to the advancement, and initiative by the regional government to ensure coverage of immunity for all, and the presence of key market players in the region. Additionally, the increasing prevalence of the benefits of DNA vaccines is expected to boosts the growth of the market in North America.

Research Methodology

The market study of the global  DNA vaccine market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global DNA Vaccine Market by Type
  • Global DNA Vaccine Market by Technology
  • Global DNA Vaccine Market by Application

The Report Covers

  • Comprehensive research methodology of the Global DNA Vaccine Market
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global DNA Vaccine Market Insights about market determinants that are stimulating the Global DNA Vaccine Market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global DNA Vaccine Industry
  • Recovery Scenario of Global DNA Vaccine Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global DNA Vaccine Market by Type
    • 5.1.1. Animal DNA Vaccine
    • 5.1.2. Human DNA Vaccine
  • 5.2. Global DNA Vaccine Market by Technology
    • 5.2.1. Plasmid DNA Vaccines Technology
    • 5.2.2. Plasmid DNA Delivery Technology
  • 5.3. Global DNA Vaccine Market by Application
    • 5.3.1. Oncology
    • 5.3.2. Infectious Diseases
    • 5.3.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Arbutus Biopharma
  • 7.2. Astellas Pharma Inc.
  • 7.3. Bayhill Therapeutics
  • 7.4. Bharat Biotech International Ltd.
  • 7.5. Dendreon Pharmaceuticals LLC.
  • 7.6. GC Pharma Corp.
  • 7.7. General Electric Co.
  • 7.8. GlaxoSmithKline plc.
  • 7.9. Hoffmann-La Roche Ltd
  • 7.10. Indian Immunologicals Ltd.
  • 7.11. INOVIO Pharmaceuticals.
  • 7.12. Merck & Co., Inc.,
  • 7.13. Pfizer Inc.
  • 7.14. QED Bioscience Inc.
  • 7.15. Sanofi S.A.
  • 7.16. Serum Institute of India Pvt. Ltd.
  • 7.17. Xenetic Biosciences, Inc.
  • 7.18. Zoetis Inc.

LIST OF TABLES

  • 1. GLOBAL DNA VACCINE MARKET BY TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL ANIMAL DNA VACCINE MARKET BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL HUMAN DNA VACCINE MARKET BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL DNA VACCINE MARKET BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 5. GLOBAL PLASMID DNA VACCINES TECHNOLOGY MARKET BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL PLASMID DNA DELIVERY TECHNOLOGY MARKET BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL DNA VACCINE MARKET BY APPLICATION, 2020-2027 ($ MILLION)
  • 8. GLOBAL DNA VACCINE IN ONCOLOGY MARKET BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL DNA VACCINE IN INFECTIOUS DISEASES MARKET BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL DNA VACCINE IN OTHERS MARKET BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL DNA VACCINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICAN DNA VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 13. NORTH AMERICAN DNA VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 14. NORTH AMERICAN DNA VACCINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 15. NORTH AMERICAN DNA VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 16. EUROPEAN DNA VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 17. EUROPEAN DNA VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 18. EUROPEAN DNA VACCINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 19. EUROPEAN DNA VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 20. ASIA-PACIFIC DNA VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 21. ASIA-PACIFIC DNA VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 22. ASIA-PACIFIC DNA VACCINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC DNA VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 24. REST OF THE WORLD DNA VACCINE MARKET RESEARCH AND ANALYSIS BY, 2020- TYPE, 2027 ($ MILLION)
  • 25. REST OF THE WORLD DNA VACCINE MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 26. REST OF THE WORLD DNA VACCINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020- TYPE2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL DNA VACCINE MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL DNA VACCINE MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL DNA VACCINE MARKET, 2021-2027 (%)
  • 4. GLOBAL DNA VACCINE MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 5. GLOBAL DNA VACCINE MARKET SHARE BY TECHNOLOGY, 2020 VS 2027 (%)
  • 6. GLOBAL DNA VACCINE MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 7. GLOBAL DNA VACCINE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBAL ANIMAL DNA VACCINEMARKET BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL HUMAN DNA VACCINEMARKET BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL PLASMID DNA VACCINES TECHNOLOGYMARKET BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL PLASMID DNA DELIVERY TECHNOLOGYMARKET BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL DNA VACCINE INONCOLOGYMARKET BY REGION, 2020 VS 2027 (%)
  • 13. GLOBALDNA VACCINE IN INFECTIOUS DISEASESMARKET BY REGION, 2020 VS 2027 (%)
  • 14. GLOBALDNA VACCINE IN OTHERSMARKET BY REGION, 2020 VS 2027 (%)
  • 15. US DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. CANADA MARKET DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. UK DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. GERMANY DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. SPAIN DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. FRANCE DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. ITALY DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. REST OF EUROPE DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. INDIA DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. CHINA DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. JAPAN DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. SOUTH KOREA DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. REST OF WORLD DNA VACCINE MARKET SIZE, 2020-2027 ($ MILLION)